medicinova

Shares of MediciNova, Inc. (NASDAQ: MNOV), a biopharmaceutical company that focuses on the treatment of serious diseases with unmet medical needs, were trading higher by more than 6 percent early Thursday morning. MediciNova announced after Wednesday's close that the medical journal Drug...

Global Hunter initiated coverage of MediciNova (NASDAQ: MNOV) with a Speculative Buy rating and a price target of $4. In a research report published today, Global Hunter states, "Our Speculative Buy rating is based on data to date, near-term milestones, attractive valuation and uncertainties...

Global Hunter Securities has initiated coverage on MediciNova (NASDAQ: MNOV) with a Buy rating and $4 price target.